 Home > Medical News > Latest Medical News > Shenzhou Cell Holding Subsidiary New Crown Neutralizing Antibody Drug Approved for Clinical Clinic

Shenzhou Cell Holding Subsidiary New Crown Neutralizing Antibody Drug Approved for Clinical Clinic

 Last Update: 2022-01-01
 Source: Internet
 Author: User

Tags

affinity drug testing

fda approval news

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On December 4, Shenzhou Cell issued an announcement stating that its holding subsidiary, Shenzhou Cell Engineering, received the "Drug Clinical Trial Approval" approved and issued by the State Food and Drug Administration.

The approval document 2021L90025 is the single-drug clinical research plan of SCTA01C, and the approval document 2021L90026 and 2021L90027 are the clinical research plan of SCTA01C and SCTA01 combination drugs

SCTA01 is a recombinant anti-SARS-CoV-2 spike protein monoclonal antibody independently developed by Shenzhou Cell Engineering.

SCTA01C is a new coronavirus monoclonal neutralizing antibody independently developed by Shenzhou Cell Engineering.

SCTA01C and SCTA01 bind to different epitopes of RBD respectively, and can bind to the same RBD together

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.